Uncategorized

SparingVision Receives European Orphan Designation for its Drug Candidate SPVN06 Dedicated to Inherited Retinal Dystrophies

by Business Wire • 2020/06/30 • 0 Comments

PARIS--(BUSINESS WIRE)--SparingVision Receives European Orphan Designation for its Drug Candidate SPVN06 Dedicated to Inherited Retinal Dystrophies